| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/107327480401100214 |
| P698 | PubMed publication ID | 15024344 |
| P2093 | author name string | Ngaire Elwood | |
| P2860 | cites work | Tankyrase, a poly(ADP-ribose) polymerase at human telomeres | Q22008022 |
| Mammalian telomeres end in a large duplex loop | Q22009893 | ||
| Ku binds telomeric DNA in vitro | Q22010395 | ||
| Normal human chromosomes have long G-rich telomeric overhangs at one end | Q22065787 | ||
| Identification of human Rap1: implications for telomere evolution | Q22254239 | ||
| Human POT1 facilitates telomere elongation by telomerase | Q24303687 | ||
| A human telomeric protein | Q24304466 | ||
| hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization | Q24310670 | ||
| Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2 | Q24317670 | ||
| Control of telomere length by the human telomeric protein TRF1 | Q24320111 | ||
| Extension of life-span by introduction of telomerase into normal human cells | Q24336088 | ||
| The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats | Q24339608 | ||
| Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation | Q24596210 | ||
| Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. | Q27640301 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| TRF2 Protects Human Telomeres from End-to-End Fusions | Q28111898 | ||
| Stem Cells | Q28111899 | ||
| Human Ku70/80 associates physically with telomerase through interaction with hTERT | Q28115815 | ||
| Pot1, the putative telomere end-binding protein in fission yeast and humans | Q28188476 | ||
| The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita | Q28189076 | ||
| The RNA component of human telomerase | Q28288330 | ||
| Identification of a specific telomere terminal transferase activity in Tetrahymena extracts | Q28306745 | ||
| Telomeric localization of TRF2, a novel human telobox protein | Q28314941 | ||
| Senescence Induced by Altered Telomere State, Not Telomere Loss | Q28315731 | ||
| p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 | Q28609749 | ||
| The serial cultivation of human diploid cell strains | Q29547356 | ||
| Telomeres shorten during ageing of human fibroblasts | Q29547357 | ||
| Telomerase catalytic subunit homologs from fission yeast and human | Q29615387 | ||
| Switching and signaling at the telomere | Q29615653 | ||
| A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes | Q29617061 | ||
| Cell cycle checkpoint signaling through the ATM and ATR kinases | Q29617837 | ||
| Essential role of mouse telomerase in highly proliferative organs | Q29620451 | ||
| Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss | Q33183485 | ||
| Differentiation of immortal cells inhibits telomerase activity. | Q33670557 | ||
| In vivo telomere dynamics of human hematopoietic stem cells | Q33726870 | ||
| p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis | Q33862956 | ||
| Telomerase activity in normal and malignant hematopoietic cells | Q33883794 | ||
| The terminal DNA structure of mammalian chromosomes | Q33886897 | ||
| Cell senescence and cancer | Q33957948 | ||
| Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics | Q33962085 | ||
| The telomere hypothesis of cellular aging | Q33973605 | ||
| The role of telomerase expression and telomere length maintenance in human and mouse | Q34001044 | ||
| Repair of telomeric DNA prior to replicative senescence | Q34034005 | ||
| Alternative lengthening of telomeres in mammalian cells | Q34114656 | ||
| Telomerase activation, cellular immortalization and cancer | Q34235187 | ||
| Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia | Q34293533 | ||
| Telomere maintenance mechanisms as a target for drug development | Q34293590 | ||
| Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation | Q34431569 | ||
| Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita | Q34514264 | ||
| Telomerase in the human organism | Q34535632 | ||
| Senescence: does it all happen at the ends? | Q34535679 | ||
| Telomeres and telomerase in hematologic neoplasia | Q34535734 | ||
| Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. | Q34724924 | ||
| Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure? | Q35015447 | ||
| Stem cells, telomerase and dyskeratosis congenita | Q35050092 | ||
| Hematopoietic stem cells and hematopoiesis | Q35071092 | ||
| It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected]. | Q35183791 | ||
| Telomeric DNA in normal and leukemic blood cells | Q35553065 | ||
| The rate of telomere sequence loss in human leukocytes varies with age. | Q36093340 | ||
| Regulated expression of telomerase activity in human T lymphocyte development and activation | Q36366852 | ||
| Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. | Q36375132 | ||
| Regulation of telomerase activity in immortal cell lines | Q36560197 | ||
| Telomere loss: mitotic clock or genetic time bomb? | Q36706939 | ||
| An overhanging 3' terminus is a conserved feature of telomeres | Q36753674 | ||
| Cell cycle-dependent modulation of telomerase activity in tumor cells. | Q37573521 | ||
| Heterogeneity in telomere length of human chromosomes. | Q39426746 | ||
| Telomerase, Cell Immortality, and Cancer | Q40431193 | ||
| Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma | Q40635344 | ||
| Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype | Q40978432 | ||
| Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. | Q41022028 | ||
| Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase | Q41053498 | ||
| Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes | Q41326041 | ||
| Human endothelial cell life extension by telomerase expression | Q41688544 | ||
| Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow | Q42528725 | ||
| Telomere length changes in patients with aplastic anaemia | Q43572280 | ||
| Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia | Q44473593 | ||
| Telomerase activity in hematopoietic cells is associated with self-renewal potential | Q46183315 | ||
| Telomere states and cell fates | Q46830116 | ||
| Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang | Q47240761 | ||
| Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change | Q47783344 | ||
| Severe growth defect in mouse cells lacking the telomerase RNA component | Q47991784 | ||
| Expression of TERT in early premalignant lesions and a subset of cells in normal tissues | Q47991825 | ||
| Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. | Q50910580 | ||
| Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. | Q52022148 | ||
| Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. | Q52109001 | ||
| Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. | Q52165691 | ||
| Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. | Q52191382 | ||
| Telomerase maintains telomere structure in normal human cells. | Q52551445 | ||
| Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. | Q53446477 | ||
| Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. | Q55067752 | ||
| The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability | Q56508014 | ||
| Tankyrase promotes telomere elongation in human cells | Q56969704 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 77-85 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Cancer Control | Q15724614 |
| P1476 | title | Telomere biology of human hematopoietic stem cells | |
| P478 | volume | 11 |
| Q40470548 | Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells. |
| Q41990866 | Effects of water, sanitation, handwashing, and nutritional interventions on telomere length among children in a cluster-randomized controlled trial in rural Bangladesh |
| Q81073576 | Functional genomics of hTERT gene in leukemic myelopoiesis |
| Q40284074 | Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal |
| Q36274746 | Postnatal stem cell survival: does the niche, a rare harbor where to resist the ebb tide of differentiation, also provide lineage-specific instructions? |
Search more.